Exane BNP Paribas

BNP Paribas acquired Exane in 2021, following a successful and exclusive 17-year partnership. As a leading European equities business, Exane BNP Paribas offers you an award winning research product renowned for its depth and quality, provided to experienced, top-ranked Sales & Specialist Sales teams as well as a dedicated corporate access service.

Access to CUBE New window

#1 Developed

Europe Research

2020 All-Europe Institutional Investor Survey


stocks covered

#1 Industry

2020 All-Europe Institutional Investor Survey


BNP Paribas acquires Exane

Following a recent announcement in March 2021, BNP Paribas has received all the necessary approvals and completed the acquisition of 100% of Exane.

Unique Research

We have invested consistently over recent cycles to build a top Equity Research franchise which was ranked #1 in Europe in the 2020 Institutional Investor Survey and in the three consecutive Extel surveys (2017, 2018, 2019). Overall, Exane Research ranks #1 in 15 equity sectors (out of 30) while being in the Top 3 position in 24 sectors.

Thanks to our focus on innovative, high quality cash equities research and data, we are able to provide top quality research products to better service our clients and strengthen our sales’ expertise.


Institutional Investor Highlights Leadership in European Equity Research

Exane BNP Paribas maintains its position as number 1 research provider for Developed Europe from Institutional Investor Research, for 5 years running

Institutional Investor Industry Reaserch 2020

Exane BNP Paribas ranked in 1st place in all headline categories in the 2020 All-Europe Research Survey from Institutional Investor. This top performance confirms the firm’s position as the leading platform in European equities, following 3 consecutive #1 positions in the previous Extel Survey.

Be the first to know

Every month, be the first to know about our latest publications